Ralaniten

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameRalaniten

Drug Alias NameEPI-002

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAndrogen Receptor antagonists

TargetsAndrogen Receptor

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEssa Pharma Inc

China Registration ClassN/A

Active CompaniesEssa Pharma Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A